San Francisco-based Virta Health has announced the closing of a $45 million Series B funding round for its digitally-delivered, drug- and surgery-free Type 2 diabetes treatment. Previous investors Venrock, Obvious Ventures, Creandum, Caffeinated Capital, and SciFi VC participated in the round, with new investors including Founders Fund and Playground Global joining as well.
from MobiHealthNews https://ift.tt/2q5Iz4g
April 04, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Chatbot campaign for flu shots bolsters patient response rate by 30%Communicating with patients can be tough. Reminder pamphlets often go straight into the rubbish and emails are deleted before they are read. But one doctor found that chatbots could be a key to patient outreach. Brett S… Read More
Free app Welloh offers patients tool to find providersConsumers now have another option to turn to when looking for a new doctor with the recent launch of mobile provider search tool Welloh. The free app is designed to help users navigate their healthcare options. It … Read More
Digital health news briefs for 1/30/2018A matter of national security. Heatmap data released this weekend by fitness app Strava appears to betray the locations of US military bases and patrol routes, according to an analyst with the Institute for United Conflict An… Read More
Amazon, Berkshire, JPMorgan Chase partner to build healthcare company with focus on techAmazon, the world’s ubiquitous online store, revealed today it is collaborating with Warren Buffet, who heads Berkshire Hathaway, and the bank JPMorgan Chase to build an independent, nonprofit healthcare company with the goal… Read More
HIMSS Precision Medicine Summit — Call for Speaking Proposals OpenHIMSS is now accepting speaking proposals for the Precision Medicine Summit, May 17-18 in Washington, DC. Precision medicine is one of the hottest and most transformative topics in healthcare, and over two days, speakers will… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment